GSK Moves To Cut Willfulness From Reed Smith Suicide Trial
GlaxoSmithKline PLC pressed an Illinois federal judge to cut claims of wanton and willful conduct from a case implicating the drugmaker in a former Reed Smith LLP partner's suicide, saying Thursday...To view the full article, register now.
Already a subscriber? Click here to view full article